Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of central nervous system (CNS) active compounds. Its structure supports the creation of bioactive molecules with potential antipsychotic, antidepressant, or anxiolytic effects. The trifluoroethyl group enhances metabolic stability and membrane permeability, making it valuable in drug design. Commonly employed in medicinal chemistry research for optimizing lead compounds and improving pharmacokinetic properties. Also utilized in the preparation of novel heterocyclic derivatives for biological screening in early-stage drug discovery.